English | Español

Allergan, Inc.
Ruth de Jauregui | Apr 22, 2017

Novartis teaming with Allergan in Phase IIb trial of non-alcoholic steatohepatitis treatment therapy
Tabitha Fleming | Jan 24, 2017

Allergan continues support for headache research

Jamie Barrand | Mar 20, 2016

New treatment available for bipolar disorder, schizophrenia
Jamie Barrand | Mar 17, 2016

Allergan's dry eye disease therapy receives prior approval supplement from FDA
Jamie Barrand | Dec 17, 2015

Allergan releases new therapy for irritable bowel syndrome
Jamie Barrand | Dec 7, 2015

Allergan partners with Rugen Therapeutics to develop autism, OCD therapies
Jamie Barrand | Oct 16, 2015

Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215
Jamie Barrand | Oct 14, 2015

Allergan releasing generic version of Invega in U.S.

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program